145 related articles for article (PubMed ID: 34719906)
1. [Serum concentration of phospholipase A2 and platelet aggregation during hyperbaric oxygen therapy in patients with ischemic heart disease].
Ruzov VI; Goryachaya MN; Altynbaeva EN; Sharafutdinova RR; Peshne EN; Kostishko BB
Vopr Kurortol Fizioter Lech Fiz Kult; 2021; 98(5):32-39. PubMed ID: 34719906
[TBL] [Abstract][Full Text] [Related]
2. [The influence of hyperbaric oxygenation on the elastic properties of platelet membrane during spontaneous platelet aggregation in the patients presenting with cardiac co-morbidity].
Ruzov VI; Altynbaeva EN; Goryachaya MN; Aryamkina OL; Kostishko BB; Chursanova NV; Vorobev AM
Vopr Kurortol Fizioter Lech Fiz Kult; 2018; 95(4):4-9. PubMed ID: 30168508
[TBL] [Abstract][Full Text] [Related]
3. [Difficulties in evaluating the efficacy of antiplatelet therapy in clinical practice].
Buriachkovskaia LI; Uchitel' IA; Sumarokov AV; Popov EG
Ter Arkh; 2009; 81(5):41-7. PubMed ID: 19537585
[TBL] [Abstract][Full Text] [Related]
4. Role of enzymatic activity in the antiplatelet effects of a phospholipase A2 from Ophiophagus hannah snake venom.
Huang MZ; Gopalakrishnakone P; Kini RM
Life Sci; 1997; 61(22):2211-7. PubMed ID: 9393940
[TBL] [Abstract][Full Text] [Related]
5. The role of hyperbaric oxygen to platelet aggregation in noninsulin-dependent diabetes mellitus (NIDDM).
Widiyanti P; Suryohudoyo P
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):617-621. PubMed ID: 34214305
[TBL] [Abstract][Full Text] [Related]
6. BE-I-PLA2, a novel acidic phospholipase A2 from Bothrops erythromelas venom: isolation, cloning and characterization as potent anti-platelet and inductor of prostaglandin I2 release by endothelial cells.
de Albuquerque Modesto JC; Spencer PJ; Fritzen M; Valença RC; Oliva ML; da Silva MB; Chudzinski-Tavassi AM; Guarnieri MC
Biochem Pharmacol; 2006 Jul; 72(3):377-84. PubMed ID: 16750518
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibitory action on platelet activation of a phospholipase A2 isolated from Lachesis muta (Bushmaster) snake venom.
Fuly AL; Machado OL; Alves EW; Carlini CR
Thromb Haemost; 1997 Nov; 78(5):1372-80. PubMed ID: 9408022
[TBL] [Abstract][Full Text] [Related]
8. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
[TBL] [Abstract][Full Text] [Related]
9. [Hyperbaric oxygenation and antiaggregants: effects on platelet function in patients with ischemic heart disease].
Seriakov VV; Feofanova ID
Anesteziol Reanimatol; 1997; (2):31-3. PubMed ID: 9221683
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen treatment induces platelet aggregation and protein release, without altering expression of activation molecules.
Shaw FL; Winyard PG; Smerdon GR; Bryson PJ; Moody AJ; Eggleton P
Clin Biochem; 2009 Apr; 42(6):467-76. PubMed ID: 19210959
[TBL] [Abstract][Full Text] [Related]
11. Effect of hyperbaric oxygen therapy on complete blood count.
Gunes AE; Aktas S
Undersea Hyperb Med; 2017; 44(4):357-364. PubMed ID: 28783892
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of the efficacy of mexidol in the combination with hyperbaric oxygen in acute ischemic stroke].
Kulai NS; Kovalchuk EY
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3. Vyp. 2):69-72. PubMed ID: 29798984
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet and anticoagulant activities of two phospholipase A2s purified from Cerastes cerastes venom: Structure-function relationship.
Fatah C; Samah S; Fatima LD
J Biochem Mol Toxicol; 2018 Dec; 32(12):e22219. PubMed ID: 30239061
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester.
Lee GY; Chang TS; Lee KS; Khil LY; Kim D; Chung JH; Kim YC; Lee BH; Moon CH; Moon CK
Thromb Res; 2005; 115(4):309-18. PubMed ID: 15668191
[TBL] [Abstract][Full Text] [Related]
15. Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
Ignjatovic V; Pavlovic S; Miloradovic V; Andjelkovic N; Davidovic G; Djurdjevic P; Stolic R; Iric-Cupic V; Simic I; Ignjatovic VD; Petrovic N; Smiljanic Z; Zdravkovic V; Simovic S; Jovanovic D; Nesic J
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):44-52. PubMed ID: 25868659
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological intervention with platelet phospholipase A2.
Nosal R; Jancinova V
Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
[TBL] [Abstract][Full Text] [Related]
17. Role of catalytic function in the antiplatelet activity of phospholipase A2 cobra (Naja naja naja) venom.
Rudrammaji LM; Machiah KD; Kantha TP; Gowda TV
Mol Cell Biochem; 2001 Mar; 219(1-2):39-44. PubMed ID: 11354251
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the enzymatic activity, anticoagulant and antiplatelet effects of phospholipase A2 isoenzymes from Naja nigricollis venom.
Kini RM; Evans HJ
Thromb Haemost; 1988 Oct; 60(2):170-3. PubMed ID: 3146138
[TBL] [Abstract][Full Text] [Related]
19. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.
Kohler C; Carroll M; Tarrant E; Torley L; Wissner A
Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926
[TBL] [Abstract][Full Text] [Related]
20. Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents.
Liu H; Fu D; Luo Y; Peng D
Sci Rep; 2022 Oct; 12(1):16609. PubMed ID: 36198899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
